New Insomnia Treatment Approved

January 16, 2020

New Insomnia Treatment Approved

Orexin receptor antagonist DAYVIGO TM has been approved for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance in adults. The medication was tested in 2,000 patients before being approved by the FDA. Clinical trials are much more than just a drug, patient and a placebo, which is why Yourway offers ancillary material sourcing, including medical equipment and devices as well as diagnostic and testing equipment.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

GCSG 2026 US Conference

April 27-29, 2026
San Diego, CA

Schedule a Meeting

Pharma Supply Chain & Logistics Innovation Programme EU

May 20-21, 2026
Basel, Switzerland

Schedule a Meeting

Media

Articles

Maintaining Temperature Integrity in Direct-to-Patient Clinical Trials

Open chat

Hello! How can I help you?